Related references
Note: Only part of the references are listed.Inhibition of RAGE Axis Signaling: A Pharmacological Challenge
Armando Rojas et al.
CURRENT DRUG TARGETS (2019)
Targeting RAGE Signaling in Inflammatory Disease
Barry I. Hudson et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
Direct binding and internalization of diverse extracellular nucleic acid species through the collagenous domain of class A scavenger receptors
Kaushal Baid et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Damage-Associated Molecular Patterns in Inflammatory Diseases
Jong Seong Roh et al.
IMMUNE NETWORK (2018)
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
V. F. A. M. Derksen et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Critical role of RAGE and HMGB1 in inflammatory heart disease
Anna Bangert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease
Niki L. Reynaert et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Avenues to autoimmune arthritis triggered by diverse remote inflammatory challenges
Nina Chevalier et al.
JOURNAL OF AUTOIMMUNITY (2016)
The Role of Follicular Helper T Cell Molecules and Environmental Influences in Autoantibody Production and Progression to Inflammatory Arthritis in Mice
Nina Chevalier et al.
ARTHRITIS & RHEUMATOLOGY (2016)
RAGE Deficiency Impairs Bacterial Clearance in Murine Staphylococcal Sepsis, but Has No Significant Impact on Staphylococcal Septic Arthritis
Majd Mohammad et al.
PLOS ONE (2016)
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Jolien Suurmond et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Deletion of Receptor for Advanced Glycation End Products Exacerbates Lymphoproliferative Syndrome and Lupus Nephritis in B6-MRL Fas lpr/j Mice
Antoine Goury et al.
JOURNAL OF IMMUNOLOGY (2015)
Antibiotic-Killed Staphylococcus aureus Induces Destructive Arthritis in Mice
Abukar Ali et al.
ARTHRITIS & RHEUMATOLOGY (2015)
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
Yu Liu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2014)
Inflammation and Lymphopenia Trigger Autoimmunity by Suppression of IL-2-Controlled Regulatory T Cell and Increase of IL-21-Mediated Effector T Cell Expansion
Nina Cheyalier et al.
JOURNAL OF IMMUNOLOGY (2014)
The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases
Melinda Magna et al.
MOLECULAR MEDICINE (2014)
Toll-like Receptor 2 Is Required for Autoantibody Production and Development of Renal Disease in Pristane-Induced Lupus
Vilma Urbonaviciute et al.
ARTHRITIS AND RHEUMATISM (2013)
Soluble Receptor for Advanced Glycation End Products Alleviates Nephritis in (NZB/NZW)F1 Mice
Sang-Won Lee et al.
ARTHRITIS AND RHEUMATISM (2013)
The receptor for advanced glycation end-products: A complex signaling scenario for a promiscuous receptor
Armando Rojas et al.
CELLULAR SIGNALLING (2013)
RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA
Cherilyn M. Sirois et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
CD11b/CD18 (Mac-1) Is a Novel Surface Receptor for Extracellular Double-Stranded RNA To Mediate Cellular Inflammatory Responses
Hui Zhou et al.
JOURNAL OF IMMUNOLOGY (2013)
RAGE regulation and signaling in inflammation and beyond
Katrin Kierdorf et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Bone-Targeting Endogenous Secretory Receptor for Advanced Glycation End Products Rescues Rheumatoid Arthritis
Tatsuo Takahashi et al.
MOLECULAR MEDICINE (2013)
Surface expression and genotypes of Toll-like receptors 2 and 4 in patients with juvenile idiopathic arthritis and systemic lupus erythematosus
Martina Kirchner et al.
PEDIATRIC RHEUMATOLOGY (2013)
Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation
Jeng-Ting Tsao et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2012)
Crosstalk between Advanced Glycation and Endoplasmic Reticulum Stress: Emerging Therapeutic Targeting for Metabolic Diseases
Christina Piperi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis
H. A. Martens et al.
LUPUS (2012)
HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease
Helena Erlandsson Harris et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
DEC-205 is a cell surface receptor for CpG oligonucleotides
Mireille H. Lahoud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The Plasma Level of Soluble Receptor for Advanced Glycation End Products is Decreased in Patients with Systemic Lupus Erythematosus
C. -Y. Ma et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications
Ravichandran Ramasamy et al.
YEAR IN DIABETES AND OBESITY (2011)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
S100A8 Enhances Osteoclastic Bone Resorption In Vitro Through Activation of Toll-like Receptor 4 Implications for Bone Destruction in Murine Antigen-Induced Arthritis
Lilyanne C. Grevers et al.
ARTHRITIS AND RHEUMATISM (2011)
Murine Models of Systemic Lupus Erythematosus
Daniel Perry et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Soluble Receptor for Advanced Glycation Endproducts Is Decreased in Patients with Juvenile Idiopathic Arthritis (ERA Category) and Inversely Correlates with Disease Activity and S100A12 Levels
Arpita Myles et al.
JOURNAL OF RHEUMATOLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Toll-Like Receptor 4 Is Involved in Inflammatory and Joint Destructive Pathways in Collagen-Induced Arthritis in DBA1J Mice
Matthias Pierer et al.
PLOS ONE (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis
Kristin Moreth et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
Karin Loser et al.
NATURE MEDICINE (2010)
RAGE and the pathogenesis of chronic kidney disease
Vivette D'Agati et al.
NATURE REVIEWS NEPHROLOGY (2010)
Binding of S100 proteins to RAGE: An update
Estelle Leclerc et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
RAGE: a novel biological and genetic marker for vascular disease
Anastasia Z. Kalea et al.
CLINICAL SCIENCE (2009)
Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus
Aurelia Lartigue et al.
JOURNAL OF IMMUNOLOGY (2009)
Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies
Isaac T. W. Harley et al.
NATURE REVIEWS GENETICS (2009)
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
Yueh-Sheng Chen et al.
ARTHRITIS RESEARCH & THERAPY (2009)
A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis
Judson M. Englert et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Overexpression of Toll-like Receptors 3 and 4 in Synovial Tissue From Patients With Early Rheumatoid Arthritis Toll-like Receptor Expression in Early and Longstanding Arthritis
Caroline Ospelt et al.
ARTHRITIS AND RHEUMATISM (2008)
Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
A. Komatsuda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis
Shahla Abdollahi-Roodsaz et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
Vilma Urbonaviciute et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis
M. L. Kowalski et al.
MEDIATORS OF INFLAMMATION (2008)
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
K. de Leeuw et al.
RHEUMATOLOGY (2007)
Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target
Diego Geroldi et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Critical role of M-tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice
Hirayasu Kai et al.
IMMUNOLOGY (2006)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
R Pullerits et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-γ
TRDJ Radstake et al.
ARTHRITIS AND RHEUMATISM (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE - A mechanism for amplification of inflammatory responses
G Basta et al.
CIRCULATION (2002)
The biology of the receptor for advanced glycation end products and its ligands
AM Schmidt et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2000)
Share Paper
